Bénédicte Lebrun‐Vignes
- Toxicology top 0.5%
- Pharmacovigilance and Adverse Drug Reactions 23
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers 9
- Pharmacology top 1%
- Drug-Induced Adverse Reactions 47
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research 10
- Rheumatology top 1%
- Urticaria and Related Conditions 18
-
- Autoimmune Bullous Skin Diseases 20
-
- Cardiac electrophysiology and arrhythmias 7
-
- Contact Dermatitis and Allergies 6
- Co-authors
- Joe‐Elie SalemJavid J. MoslehiAli ManouchehriDan M. RodenJustin M. BalkoDouglas B. JohnsonMelissa MoeyJean‐Philippe Spano
- Cited by
- ToxicologyOncologyPharmacology
- Journals
- Circulation (2 papers)Nature Communications (1 paper)Journal of the American College of Cardiology (1 paper)
- Partner nations
- FranceUnited StatesBelgium
In The Last Decade
Bénédicte Lebrun‐Vignes
111 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Toxicology 214
- Oncology 1.4k
- Pharmacology 812
- Genetics 478
- Rheumatology 614
Countries citing papers authored by Bénédicte Lebrun‐Vignes
This map shows the geographic impact of Bénédicte Lebrun‐Vignes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bénédicte Lebrun‐Vignes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bénédicte Lebrun‐Vignes more than expected).
Fields of papers citing papers by Bénédicte Lebrun‐Vignes
This network shows the impact of papers produced by Bénédicte Lebrun‐Vignes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bénédicte Lebrun‐Vignes. The network helps show where Bénédicte Lebrun‐Vignes may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bénédicte Lebrun‐Vignes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 4 | |
| 3 | Clinical spectrum and evolution of immune-checkpoint inhibitors toxicities over a decade—a worldwide perspectivebreakdown → | 2024 | 67 |
| 4 | 2023 | 1 | |
| 5 | 2023 | 0 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 9 | |
| 8 | 2022 | 0 | |
| 9 | 2022 | 15 | |
| 10 | Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance databasebreakdown → | 2022 | 99 |
| 11 | 2021 | 3 | |
| 12 | 2020 | 161 | |
| 13 | 2020 | 7 | |
| 14 | 2019 | 115 | |
| 15 | Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance studybreakdown → | 2019 | 260 |
| 16 | 2019 | 3 | |
| 17 | 2018 | 39 | |
| 18 | 2015 | 1 | |
| 19 | 2014 | 15 | |
| 20 | 2007 | 30 |
About Bénédicte Lebrun‐Vignes
Bénédicte Lebrun‐Vignes is a scholar working on Toxicology, Pharmacology and Rheumatology, having authored 120 papers that have together received 3.9k indexed citations. Recurring topics across this work include Drug-Induced Adverse Reactions (47 papers), Pharmacovigilance and Adverse Drug Reactions (23 papers), Autoimmune Bullous Skin Diseases (20 papers), Urticaria and Related Conditions (18 papers), Chronic Lymphocytic Leukemia Research (10 papers), Cancer Immunotherapy and Biomarkers (9 papers), Cardiac electrophysiology and arrhythmias (7 papers) and Contact Dermatitis and Allergies (6 papers). The work is most often cited by research in Toxicology (214 citations), Oncology (1.4k citations) and Pharmacology (812 citations). Bénédicte Lebrun‐Vignes has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include Joe‐Elie Salem, Javid J. Moslehi, Ali Manouchehri, Dan M. Roden, Justin M. Balko, Douglas B. Johnson, Melissa Moey, Jean‐Philippe Spano, Christian Funck‐Brentano and Alexandre Pariente. Their work appears in journals such as Circulation, Nature Communications and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.